Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people
PLOS Pathogens · 25.11.2025 · 21 (11) · e1013702
DOI: 10.1371/journal.ppat.1013702 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 25.11.2025. Verfasst von Tine Struyve und 8 weiteren Autor:innen. Beteiligte Einrichtung: HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Virus Integration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FWO Vlaanderen, VLAIO.
Abstract (Originalsprache)
Persistence of the HIV-1 reservoir is the major barrier to a cure. Little is known about the dynamics of the proviral integration site landscape and inducibility of the viral reservoir in early-treated individuals. Here, we perform a longitudinal analysis of the viral reservoir in individuals who started treatment during acute infection and compare these findings to chronically-treated individuals. Even in early-treated individuals, clonal expansion contributes to reservoir persistence. Integration site analysis reveals similar distributions after one year of antiretroviral therapy (ART), irrespective of treatment initiation timing. Notably, proviruses integrated in heterochromatin regions are already detected in early-treated individuals after one year on ART and are progressively enriched after five years on ART, suggesting post-integration selection mechanisms. Using a lipid nanoparticle containing Tat mRNA (Tat-LNP) in combination with phorbol myristate acetate (PMA), we detect for the first time the inducible reservoir in individuals treated during acute infection with small reservoir sizes. Furthermore, we show that, in both the acute and chronic cohorts, the inducible reservoir shifts towards a more differentiated T cell compartment over time. Collectively, these findings indicate that clonal expansion and integration site selection contribute to reservoir persistence early after ART initiation in individuals treated shortly after seroconversion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium.
- Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
- Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
ORCID-Profile: Tine Struyve, Linos Vandekerckhove
Förderung
- NIAID NIH HHS
- FWO Vlaanderen
- VLAIO
- Ghent University Special Research Fund
- National Institutes of Health
Zitieren
APA
Struyve, T., Pardons, M., De Clercq, J., Termote, L., Lambrechts, L., Noppe, Y., Lichterfeld, M., Rutsaert, S., & Vandekerckhove, L. (2025). Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people. PLOS Pathogens, 21(11), e1013702. https://doi.org/10.1371/journal.ppat.1013702
Vancouver
Struyve T, Pardons M, De Clercq J, Termote L, Lambrechts L, Noppe Y, et al. Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people. PLOS Pathogens. 2025;21(11):e1013702. doi:10.1371/journal.ppat.1013702
BibTeX
@article{Struyve2025,
author = {Struyve, Tine and Pardons, Marion and De Clercq, Jozefien and Termote, Liesbet and Lambrechts, Laurens and Noppe, Ytse and Lichterfeld, Mathias and Rutsaert, Sofie and Vandekerckhove, Linos},
title = {Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people},
journal = {PLOS Pathogens},
year = {2025},
volume = {21},
number = {11},
pages = {e1013702},
doi = {10.1371/journal.ppat.1013702}
}
EUVIMED